Doc. MUDr. Jaroslav Bačovský, CSc. – jubilující
Published in:
Transfuze Hematol. dnes,30, 2024, No. 2, p. 131-132.
Category:
Personal News
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2024 Issue 2
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
- Minimum and Optimal Factor Levels in Physically Active Hemophiliacs
Most read in this issue
- VEXAS syndrome – a diagnosis at the interface of rheumatology and haematology
- VEXAS syndrome – newly described autoinflammatory disease with haematologic symptoms. Case report and review of the literature
- Disorders induced by deposits of monoclonal immunoglobulin IgM and free light chain in Waldenström’s macroglobulinaemia – case report and review of literature
- Splanchnic vein thrombosis: aetiology, therapy, and results – a retrospective analysis